Ghana vs Senegal: Cause of death, by non-communicable diseases, ages 0-4, female
Ghana
11.4%
in 2021
Senegal
11.2%
in 2021
Ghana rank
143rd
Senegal rank
144th
Cause of death, by non-communicable diseases, ages 0-4, female over time
- Ghana
- Senegal
How they compare
Ghana currently reports 11.4% against 11.2% in Senegal, a difference of 0.2%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Senegal ahead.
Ghana ranks 143rd and Senegal ranks 144th of 185 countries.
Senegal has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ghana | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.8% | 5.2% | 0.4% | Senegal |
| 2010s | 8.7% | 10.4% | 1.7% | Senegal |
| 2020s | 11.1% | 11.3% | 0.3% | Senegal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, female, Ghana or Senegal?
- Ghana, at 11.4% against 11.2% in Senegal as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, female between Ghana and Senegal?
- 0.2%, with Ghana ahead.
- How many years of comparable data are there for Ghana and Senegal?
- 6 years are reported by both, from 2000 to 2021.
- How do Ghana and Senegal rank globally for cause of death, by non-communicable diseases, ages 0-4, female?
- Ghana ranks 143rd and Senegal ranks 144th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, female (% of total female deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 0-4 due to non-communicable diseases divided by number of all female deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.